| Name | 2-bromo-N-(5-methyl-1,2-oxazol-3-yl)acetamide |
|---|
| Molecular Formula | C6H7BrN2O2 |
|---|---|
| Molecular Weight | 219.03600 |
| Exact Mass | 217.96900 |
| PSA | 55.13000 |
| LogP | 1.38940 |
| HS Code | 2934999090 |
|---|
|
~56%
92947-26-7 |
| Literature: RVX Therapeutics Inc.; McLure, Kevin G.; Young, Peter R. Patent: US2013/281398 A1, 2013 ; Location in patent: Paragraph 0549; 0550 ; |
|
~%
92947-26-7 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2006/48225 A1, 2006 ; Location in patent: Page/Page column 19 ; WO 2006/048225 A1 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |